To the content
4 . 2017

Liver condition in TB/HIV patients on TB and cART treatment

AbstractThe articLe anaLyzes the frequency of hepatotoxic reactions in 173 patients with newLy diagnosed TB patients with HIV infection who were treated in a TB hospitaL. Dynamics of hepatic transaminases and biLirubin was evaLuated. The frequency of severe Liver injury (III-IV degrees) was Low, not exceeding 17.7%. In 1/4 of patients, abnormaLities of biochemicaL indices were not reveaLed. The most frequentLy encountered an increase in transaminase LeveLs I-II degrees (61.8% of patients), did not request a correction TB therapy. It was found that the risk factors for hepatotoxicity, such as the presence of chronic viraL hepatitis, the use of anti-TB second Line drugs, combined treatment with anti-TB and antiretroviraL drugs do not have a negative impact on the functionaL state of the Liver in patients with combination of TB and HIV.

Keywords:tuberculosis, Human immunodeficiency virus, hepatotoxicity, anti-TB treatment

Infectious Diseases: News, Opinions, Training. 2017; (4): 45-50.
DOI: 10.24411/2305-3496-2017-00067


All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»